| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
in00002492463 |
| 005 |
20211202191532.0 |
| 006 |
m d f |
| 007 |
cr bn||||||||| |
| 008 |
090505s2009 mdu s f000 0 eng c |
| 035 |
|
|
|a (OCoLC)ocn320234159
|
| 040 |
|
|
|a GPO
|c GPO
|d GPO
|d MvI
|d UtOrBLW
|
| 042 |
|
|
|a pcc
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a WWW
|
| 074 |
|
|
|a 0499-T (online)
|
| 086 |
0 |
|
|a HE 20.4702:B 52/DRAFT
|
| 245 |
0 |
0 |
|a Guidance for industry :
|b submission of summary bioequivalence data for ANDAs.
|
| 246 |
3 |
0 |
|a Submission of summary bioequivalence data for ANDAs
|
| 264 |
|
1 |
|a Silver Spring, MD :
|b U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,
|c [2009]
|
| 300 |
|
|
|a i, 9 pages :
|b digital, PDF file.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 538 |
|
|
|a Mode of access: Internet from the CDER web site. Address as of 5/5/09: http://www.fda.gov/cder/guidance/8363dft.pdf ; current access available via PURL.
|
| 500 |
|
|
|a Title from title screen (viewed on May 5, 2009).
|
| 500 |
|
|
|a "Draft guidance."
|
| 500 |
|
|
|a "April 2009."
|
| 500 |
|
|
|a Electronic resource.
|
| 650 |
|
0 |
|a Drugs
|z United States
|x Therapeutic equivalency.
|
| 650 |
|
0 |
|a Drugs
|x Certification
|z United States.
|
| 710 |
2 |
|
|a Center for Drug Evaluation and Research (U.S.)
|
| 856 |
4 |
0 |
|u https://purl.fdlp.gov/GPO/LPS112216
|t 0
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s b785d3df-e9af-36ac-899d-73d0c41298ce
|i 0ee9a658-086c-333a-a1f2-768b1e539886
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e HE 20.4702:B 52/DRAFT
|h Superintendent of Documents classification
|
| 998 |
f |
f |
|a HE 20.4702:B 52/DRAFT
|t 0
|l Available Online
|